Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebcinal vs Tobi Bioequivalence in Cystic Fibrosis
NCT01288170Phase 2Unknown
- Sponsor
- Erempharma
- Start
- Feb 2010
- Primary completion
- Jul 2010
- Countries
- 1
01
Overview
A Phase 2 trial of tobramycin in cystic fibrosis (CF), sponsored by Erempharma. Status: unknown.
02
Drugs
tobramycin
03
Conditions
cystic fibrosis (CF)
Beyond the preview
Go deeper on NCT01288170.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288170.